Tackling the ethical considerations of dementia research Tackling the ethical considerations of dementia research Alzheimer’s research poses tricky questions. Bedside-nurse-turned-bioethicist Emily Largent wants to answer them, and to improve the lives of Alzheimer’s patients.
New mRNA vaccine to fight 20 known subtypes of influenza Image: Bernard Chantal for Adobe Stock New mRNA vaccine to fight 20 known subtypes of influenza Heading into clinical trials, the new research from Penn Medicine may serve as a general preventative measure against future flu pandemics.
Recently discovered virus family infects a human oral amoeba Penn In the News The Scientist Recently discovered virus family infects a human oral amoeba A study by Frederic Bushman of the Perelman School of Medicine and colleagues points to a human oral amoeba as the host for a recently discovered family of DNA viruses. Antibiotics encoded in Neanderthal DNA could help us fight infections Penn In the News New Scientist Antibiotics encoded in Neanderthal DNA could help us fight infections César de la Fuente of the Perelman School of Medicine and colleagues have identified extinct antibiotic molecules in ancient mitochondrial DNA that could be revived to help fight infections. Second death tied to experimental Alzheimer’s treatment Penn In the News Smithsonian Magazine Second death tied to experimental Alzheimer’s treatment Jason Karlawish of the Perelman School of Medicine notes the benefits and risks of experimental Alzheimer’s drug lecanemab. CAR T cell therapy reaches beyond cancer CAR T cell therapy reaches beyond cancer Penn Medicine researchers laud the early results for CAR T therapy in lupus patients, which point to broader horizons for the use of personalized cellular therapies. One step closer to a universal flu vaccine? Penn In the News The New York Times One step closer to a universal flu vaccine? Scott Hensley of the Perelman School of Medicine and colleagues are developing a vaccine that could be used against the entire family of flu viruses, acting as a shield against potential pandemic threats. Alzheimer’s drug may benefit some patients, new data shows Penn In the News The New York Times Alzheimer’s drug may benefit some patients, new data shows Jason Karlawish of the Perelman School of Medicine says that the new data on experimental Alzheimer’s drug lecanemab show reason for both optimism and caution. Healthcare organizations are finding novel uses for virtual health technology Penn In the News Forbes Healthcare organizations are finding novel uses for virtual health technology The Perelman School of Medicine’s Care Connect program is spearheading the use of virtual urgent care services and substance abuse professionals to provide treatment to patients, with a quote from Margaret Lowenstein. UPenn has promising early results of new flu vaccine Penn In the News CBS Philadelphia UPenn has promising early results of new flu vaccine Scientists at the Perelman School of Medicine are testing a flu vaccine that can adapt to new viral strains using the same mRNA technology as the Pfizer and Moderna COVID-19 vaccines. Load More
Antibiotics encoded in Neanderthal DNA could help us fight infections Penn In the News New Scientist Antibiotics encoded in Neanderthal DNA could help us fight infections César de la Fuente of the Perelman School of Medicine and colleagues have identified extinct antibiotic molecules in ancient mitochondrial DNA that could be revived to help fight infections. Second death tied to experimental Alzheimer’s treatment Penn In the News Smithsonian Magazine Second death tied to experimental Alzheimer’s treatment Jason Karlawish of the Perelman School of Medicine notes the benefits and risks of experimental Alzheimer’s drug lecanemab. CAR T cell therapy reaches beyond cancer CAR T cell therapy reaches beyond cancer Penn Medicine researchers laud the early results for CAR T therapy in lupus patients, which point to broader horizons for the use of personalized cellular therapies. One step closer to a universal flu vaccine? Penn In the News The New York Times One step closer to a universal flu vaccine? Scott Hensley of the Perelman School of Medicine and colleagues are developing a vaccine that could be used against the entire family of flu viruses, acting as a shield against potential pandemic threats. Alzheimer’s drug may benefit some patients, new data shows Penn In the News The New York Times Alzheimer’s drug may benefit some patients, new data shows Jason Karlawish of the Perelman School of Medicine says that the new data on experimental Alzheimer’s drug lecanemab show reason for both optimism and caution. Healthcare organizations are finding novel uses for virtual health technology Penn In the News Forbes Healthcare organizations are finding novel uses for virtual health technology The Perelman School of Medicine’s Care Connect program is spearheading the use of virtual urgent care services and substance abuse professionals to provide treatment to patients, with a quote from Margaret Lowenstein. UPenn has promising early results of new flu vaccine Penn In the News CBS Philadelphia UPenn has promising early results of new flu vaccine Scientists at the Perelman School of Medicine are testing a flu vaccine that can adapt to new viral strains using the same mRNA technology as the Pfizer and Moderna COVID-19 vaccines. Load More
Second death tied to experimental Alzheimer’s treatment Penn In the News Smithsonian Magazine Second death tied to experimental Alzheimer’s treatment Jason Karlawish of the Perelman School of Medicine notes the benefits and risks of experimental Alzheimer’s drug lecanemab. CAR T cell therapy reaches beyond cancer CAR T cell therapy reaches beyond cancer Penn Medicine researchers laud the early results for CAR T therapy in lupus patients, which point to broader horizons for the use of personalized cellular therapies. One step closer to a universal flu vaccine? Penn In the News The New York Times One step closer to a universal flu vaccine? Scott Hensley of the Perelman School of Medicine and colleagues are developing a vaccine that could be used against the entire family of flu viruses, acting as a shield against potential pandemic threats. Alzheimer’s drug may benefit some patients, new data shows Penn In the News The New York Times Alzheimer’s drug may benefit some patients, new data shows Jason Karlawish of the Perelman School of Medicine says that the new data on experimental Alzheimer’s drug lecanemab show reason for both optimism and caution. Healthcare organizations are finding novel uses for virtual health technology Penn In the News Forbes Healthcare organizations are finding novel uses for virtual health technology The Perelman School of Medicine’s Care Connect program is spearheading the use of virtual urgent care services and substance abuse professionals to provide treatment to patients, with a quote from Margaret Lowenstein. UPenn has promising early results of new flu vaccine Penn In the News CBS Philadelphia UPenn has promising early results of new flu vaccine Scientists at the Perelman School of Medicine are testing a flu vaccine that can adapt to new viral strains using the same mRNA technology as the Pfizer and Moderna COVID-19 vaccines. Load More
CAR T cell therapy reaches beyond cancer CAR T cell therapy reaches beyond cancer Penn Medicine researchers laud the early results for CAR T therapy in lupus patients, which point to broader horizons for the use of personalized cellular therapies.
One step closer to a universal flu vaccine? Penn In the News The New York Times One step closer to a universal flu vaccine? Scott Hensley of the Perelman School of Medicine and colleagues are developing a vaccine that could be used against the entire family of flu viruses, acting as a shield against potential pandemic threats. Alzheimer’s drug may benefit some patients, new data shows Penn In the News The New York Times Alzheimer’s drug may benefit some patients, new data shows Jason Karlawish of the Perelman School of Medicine says that the new data on experimental Alzheimer’s drug lecanemab show reason for both optimism and caution. Healthcare organizations are finding novel uses for virtual health technology Penn In the News Forbes Healthcare organizations are finding novel uses for virtual health technology The Perelman School of Medicine’s Care Connect program is spearheading the use of virtual urgent care services and substance abuse professionals to provide treatment to patients, with a quote from Margaret Lowenstein. UPenn has promising early results of new flu vaccine Penn In the News CBS Philadelphia UPenn has promising early results of new flu vaccine Scientists at the Perelman School of Medicine are testing a flu vaccine that can adapt to new viral strains using the same mRNA technology as the Pfizer and Moderna COVID-19 vaccines. Load More
Alzheimer’s drug may benefit some patients, new data shows Penn In the News The New York Times Alzheimer’s drug may benefit some patients, new data shows Jason Karlawish of the Perelman School of Medicine says that the new data on experimental Alzheimer’s drug lecanemab show reason for both optimism and caution. Healthcare organizations are finding novel uses for virtual health technology Penn In the News Forbes Healthcare organizations are finding novel uses for virtual health technology The Perelman School of Medicine’s Care Connect program is spearheading the use of virtual urgent care services and substance abuse professionals to provide treatment to patients, with a quote from Margaret Lowenstein. UPenn has promising early results of new flu vaccine Penn In the News CBS Philadelphia UPenn has promising early results of new flu vaccine Scientists at the Perelman School of Medicine are testing a flu vaccine that can adapt to new viral strains using the same mRNA technology as the Pfizer and Moderna COVID-19 vaccines. Load More
Healthcare organizations are finding novel uses for virtual health technology Penn In the News Forbes Healthcare organizations are finding novel uses for virtual health technology The Perelman School of Medicine’s Care Connect program is spearheading the use of virtual urgent care services and substance abuse professionals to provide treatment to patients, with a quote from Margaret Lowenstein. UPenn has promising early results of new flu vaccine Penn In the News CBS Philadelphia UPenn has promising early results of new flu vaccine Scientists at the Perelman School of Medicine are testing a flu vaccine that can adapt to new viral strains using the same mRNA technology as the Pfizer and Moderna COVID-19 vaccines. Load More
UPenn has promising early results of new flu vaccine Penn In the News CBS Philadelphia UPenn has promising early results of new flu vaccine Scientists at the Perelman School of Medicine are testing a flu vaccine that can adapt to new viral strains using the same mRNA technology as the Pfizer and Moderna COVID-19 vaccines.